Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.


Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Live Pharma News Articles ...

Proteros teams up with Johnson & Johnson Innovation on sub-class of epigenetic targets
http://www.bionity.com, , 28-Jul-2017
AstraZeneca's lung cancer immunotherapy trial fails to meet primary endpoint
http://clinicaltrials.pharmaceutical-business-review.com, , 28-Jul-2017
Roche receives FDA clearance for new high-volume testing immunoassay solution
http://www.news-medical.net, , 28-Jul-2017
Fortune names Quest Diagnostics as one of ‘World's Most Admired Companies’ for 2017
http://www.news-medical.net, , 28-Jul-2017
Heska Adds Growth Capital with $30 Million Credit Agreement with JPMorgan Chase
http://www.prnewswire.com, , 28-Jul-2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha® (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
http://www.prnewswire.com, , 27-Jul-2017
Evofem Biosciences Announces First Patient Enrolled in a Phase 3 Clinical Trial of AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) for Prevention of Pregnancy
http://www.prnewswire.com, , 27-Jul-2017
Evofem Biosciences Announces First Patient Enrolled in a Phase 3 Clinical Trial of AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) for Prevention of Pregnancy
Bavarian Nordic, Johnson & Johnson join forces to develop HIV, HBV shots in $879M deal
http://www.fiercepharma.com, , 27-Jul-2017
Otsuka Announces the Acquisition of Rapidly Growing Plant-Based Food Innovator Daiya
http://www.prnewswire.com, , 27-Jul-2017
Civitas Proudly Takes Ownership of Missouri City Senior Living Community
http://www.prnewswire.com, , 27-Jul-2017
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to $8.5B
http://www.fiercepharma.com, , 27-Jul-2017
GlaxoSmithKline's talk of leaving rare diseases—amid slow Strimvelis sales—highlights challenges in the field
http://www.fiercepharma.com, , 27-Jul-2017
RegeneRx Updates on RGN-259 Phase 3 Dry Eye Trial
http://www.prnewswire.com, , 27-Jul-2017
Ultragenyx: An Interesting Company In The Rare Disease Space
https://seekingalpha.com, , 27-Jul-2017
AstraZeneca and Merck establish strategic oncology collaboration
http://www.worldpharmanews.com, , 27-Jul-2017
Beckman Coulter Diagnostics Introduces DxONE™ Clinical Information Management Tools
http://www.prnewswire.com, , 27-Jul-2017
Evotec, Storm Therapeutics to exploit RNA modulating enzymes for epigenetic drug discovery
http://drugdiscovery.pharmaceutical-business-review.com, , 27-Jul-2017
Eagle gets complete response letter from FDA on stroke drug RYANODEX
http://processandproduction.pharmaceutical-business-review.com, , 27-Jul-2017
Cerus Announces Collaboration with Central California Blood Center to Manufacture ...
http://www.biomedreports.com, , 27-Jul-2017
Showing Records 0 ... 20  


SciBite
The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts

About/Links

Query: Live Pharma News
Type: Query